This article presents a corrigendum to the 2022 EANO guidelines for adult diffuse gliomas. It addresses identified inaccuracies in diagnostic criteria and therapeutic algorithms, ensuring alignment with current molecular classifications and evidence-based management strategies to standardize clinical practice.